iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionGlen Eagle Advisors, LLC
Latest Disclosed Ownership197 shares
Latest Disclosed Value $ 33,218
Glen Eagle Advisors, LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Glen Eagle Advisors, LLC filed a 13F-HR form disclosing ownership of 197 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $33,218 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 197 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $25,817 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 197 0 0.00 33 0.00 0.0047
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 197 0 0.00 33 17.86 0.0045
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 197 0 0.00 28 16.67 0.0039
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 197 0 0.00 25 -4.00 0.0038
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 197 1 0.51 25 0.00 0.0042
2025-02-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 196 0 0.00 26 -10.71 0.0043
2024-11-15 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 196 -615 -75.83 29 -74.77 0.0048
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 811 0 0.00 111 0.00 0.0204
2024-07-03 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 811 0 0.00 111 0.91 0.0211
2024-08-13 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 811 265 48.53 110 66.67 0.0229
2024-08-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 546 -25 -4.38 67 -8.33 0.0155
2024-08-13 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 571 0 0.00 72 -1.37 0.0167
2024-08-13 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 571 0 0.00 74 -1.35 0.0185
2024-08-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 571 375 191.33 75 236.36 0.0205
2024-08-13 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 196 0 0.00 23 -4.35 0.0066
2024-08-13 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 196 0 0.00 23 -8.00 0.0062
2024-08-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 196 0 0.00 26 -13.79 0.0067
2024-08-13 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 196 0 0.00 30 -6.45 0.0078
2024-08-13 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 196 105 115.38 32 121.43 0.0092
2024-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 91 0 0.00 15 7.69 0.0046
2024-08-13 2021-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 91 -60 -39.74 14 -40.91 0.0048
2024-08-13 2020-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 151 0 0.00 23 10.00 0.0090
2024-08-13 2020-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 151 0 0.00 20 0.00 0.0092
2024-08-13 2020-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 151 0 0.00 21 25.00 0.0106
2024-08-13 2020-03-31 13F ISHARES TR ISHARES TR 464287556 151 0 0.00 16 -11.11 0.0114
2024-08-13 2019-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 151 1 0.67 18 28.57 0.0097
2024-08-13 2019-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 0.00 15 -12.50 0.0099
2024-08-13 2019-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 0.00 16 0.00 0.0112
2024-08-13 2019-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 0.00 17 14.29 0.0122
2024-08-13 2018-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 0.00 14 -22.22 0.0122
2024-08-13 2018-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 0.00 18 12.50 0.0131
2024-08-13 2018-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 0.00 16 0.00 0.0129
2024-08-14 2018-03-31 13F/A-1 ISHARES TR ISHARES TR 464287556 150 0 0.00 16 0.00 0.0132
2024-08-13 2018-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 150 0 16 0.0132
2024-08-13 2017-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 150 100 200.00 16 0.00 0.0139
2024-08-13 2017-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 50 0 0.00 17 6.67 0.0156
2024-08-13 2017-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 50 0 0.00 16 7.14 0.0124
2024-08-13 2017-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 50 -4 -7.41 15 0.00 0.0126
2024-08-13 2016-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 54 54 14 0.0129
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.